HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[The recent advance of treatment of Parkinson's disease].

Abstract
The primary pathology of Parkinson's disease is the degeneration of dopaminergic neurons in the nigrostriatal pathway, resulting in a significant reduction in striatum dopamine concentration which is responsible for the altered motor functions. With time and disease progression, efficacy of dopaminergic therapy becomes unpromising. We herein review the recent advance of treatment of Parkinson's disease to prevent ongoing progressive nature of Parkinson's disease.
AuthorsEtsuro Matsubara
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 62 Issue 9 Pg. 1725-8 (Sep 2004) ISSN: 0047-1852 [Print] Japan
PMID15462392 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Antiparkinson Agents
Topics
  • Antiparkinson Agents (therapeutic use)
  • Humans
  • Parkinson Disease (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: